GlassScriptPhysician profile
Joshua D Stein
NPI 1497929194
$10,455.20
in general payments reported to CMS, 2019-2025
9 companies · $1,373 in 2025
The $1,373 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,877 · 2020: $713 · 2021: $3,634 · 2022: $2,190 · 2023: $131 · 2024: $538 · 2025: $1,373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,164 · Travel and Lodging: $877.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,164.17 |
| Travel and Lodging | $876.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $7,865.16 | 2019-2025 | |
| Arthrex, INC. | $1,987.26 | 2022-2025 | |
| Smith+Nephew, INC. | $384.03 | 2019-2024 | Bone Anchors With Arthroscopic Delivery System, Healicoil, Spatial Frame |
| Linvatec Corporation | $106.61 | 2024 | Biobrace 23mm |
| Stryker Corporation | $52.82 | 2024-2025 | Inspace, Iconix, Procinch |
| Vertex Pharmaceuticals Incorporated | $16.82 | 2025 | |
| Depuy Synthes Sales INC. | $14.38 | 2023 | Orthovisc, Monovisc |
| Pacira Therapeutics, INC. | $14.30 | 2019 | |
| Ferring Pharmaceuticals INC. | $13.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Stein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.